Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for GH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -222.87M
March 31, 2026 -181.07M
December 31, 2025 -99.31M
September 30, 2025 -354.47M
June 30, 2025 -305.48M
March 31, 2025 -250.79M
December 31, 2024 -139.65M
September 30, 2024 -60.10M
June 30, 2024 -1.613M
March 31, 2024 68.28M
December 31, 2023 158.68M
September 30, 2023 228.30M
June 30, 2023 292.73M
March 31, 2023 -44.55M
December 31, 2022 60.18M
September 30, 2022 166.74M
June 30, 2022 319.09M
March 31, 2022 533.04M
Date Value
December 31, 2021 645.00M
September 30, 2021 709.42M
June 30, 2021 788.06M
March 31, 2021 847.05M
December 31, 2020 1.298B
September 30, 2020 1.092B
June 30, 2020 1.115B
March 31, 2020 785.11M
December 31, 2019 798.39M
September 30, 2019 815.40M
June 30, 2019 815.47M
March 31, 2019 468.13M
December 31, 2018 483.15M
September 30, 2018 255.19M
June 30, 2018 276.78M
March 31, 2018
December 31, 2017 308.61M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Natera, Inc. 1.821B
NeoGenomics, Inc. 785.73M
Quest Diagnostics, Inc. 7.516B
Labcorp Holdings, Inc. 8.607B
OPKO Health, Inc. 1.184B

Shareholders Equity (Quarterly) Related Metrics